Galway, Ireland, March 12 – AOTI Ltd. announced today that it will showcase its revolutionary wound care products and present multiple clinical research papers on the benefits of its novel topical oxygen therapy at the upcoming EWMA meeting in Geneva, Switzerland from May 29- June 2, 2010.”
“The annual EWMA meeting is one of the pre-eminent wound care educational programs in the world” stated Mike Griffiths, CEO and President of AOTI Ltd. “providing AOTI an ideal venue to demonstrate the true value of its revolutionary wound care products to key medical sales and marketing professionals throughout Europe, the Middle-East, and Southeast Asia.
“The multiple clinical research papers being presented on our behalf further demonstrate the tremendous wound healing benefits of Topical Wound Oxygen therapy and that adding this novel therapy to existing wound care best practices will not only reduce the total cost of care, but more importantly improve the patient’s quality of life”, added Griffiths.
About AOTI
AOTI is founded on a decade of experience in providing innovative solutions to resolve severe and chronic wounds worldwide. Our products reduce healthcare costs and improve the quality of life for patients with these debilitating illnesses. Our patented non-invasive Topical Wound Oxygen (two2) therapy is unsurpassed in fully closings Diabetic, Venous and Pressure ulcers alike. AOTI is a private company based in Galway, Ireland with offices throughout the globe. For more information, see www.dev.aotinc.net.
